Outbreak of Shiga Toxin-Producing Escherichia coli O111:H8 Infections among Attendees of a High School Cheerleading Camp

Clinical Infectious Diseases

Volumn 38, Issue 2, 2004, Pages 190-198

  Brooks, John T ^a,c,f   Bergmire Sweat, David ^d   Kennedy, Malinda ^a   Hendricks, Kate ^d   Garcia, Marianne ^e   Marengo, Lisa ^d   Wells, Joy ^a   Ying, Michelle ^a   Bibb, William ^a   Griffin, Patricia M ^a   Hoekstra, Robert M ^b   Friedman, Cindy R ^a  

^a Foodborne and Diarrheal Dis Branch   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Infect Dis Epidemiol Survlnc D   (United States)

^e TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTEROBACTER INFECTION; EPIDEMIC; ESCHERICHIA; ESCHERICHIA COLI O111; ESCHERICHIA COLI O157; FECES ANALYSIS; FEMALE; FOOD INTAKE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION RISK; INTERVIEW; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST; SERODIAGNOSIS; SEROTYPE;

ADOLESCENT; ADULT; CHILD; DISEASE OUTBREAKS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MIDDLE AGED; SEROLOGIC TESTS; SHIGA TOXIN; TEXAS;

EID: 9144228662     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/380634     Document Type: Article

References (52)

1. Griffin PM, Ostroff SM, Tauxe RV, et al. Illnesses associated with Escherichia coli O157:H7 infections: a broad clinical spectrum [review]. Ann Intern Med 1988; 109:705-12.
2. Besser RE, Griffin PM, Slutsker L. Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease. Annu Rev Med 1999; 50:355-67.
3. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5:607-25.
4. Griffin PM. Epidemiology of Shiga toxin-producing Escherichia coli infections in humans in the United States. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:15-22.
5. Spika JS, Khakhria R, Michel P, Milley D, Wilson J, Waters J. Shiga toxin-producing Escherichia coli infections in Canada. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:23-9.
6. Acheson D, Ngo T, Chitrakar R. Prevalence of O157 and non-O157 STEC in the United States [abstract 225]. In: Program and abstracts of the 4th International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections (Kyoto, Japan). VTEC 2000 Organizing Committee, 2000:107
7. Florentino T, Hurd S, Howard R, Wells C, Phan Q, Hadler JL. Emergence of non-culture methods for detecting Shiga toxin-producing E. coli (STEC) in Connecticut (CT) laboratories, 2000 [abstract C-166]. In: Program and abstracts of the 101st General Meeting of the American Society for Microbiology (Orlando, FL). Washington, DC: American Society for Microbiology, 2001. Available at: http://www.asmusa.org/ memonly/abstracts/AbstractView.asp?AbstractID=47955. Accessed 15 December 2003.
8. Nims L, Horensky DS, Buck LL, et al. Isolation of Shiga toxin-producing Escherichia coli in New Mexico [abstract C-165]. In: Program and abstracts of the 101st General Meeting of American Society for Microbiology (Orlando, FL). Washington, DC: American Society for Microbiology, 2001. Available at: http://www.asmusa.org/ memonly/abstracts/AbstractView.asp?AbstractID=47865. Accessed 15 December 2003.
9. Pai CH, Ahmed N, Lior H, Johnson WM, Sims HV, Woods DE. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis 1988; 157:1054-7.
10. Ritchie M, Partington S, Jessop J, Kelly MT. Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection. J Clin Microbiol 1992; 30:461-4.
11. Bokete TN, O'Callahan CM, Clausen CR, et al. Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology 1993; 105:1724-31 (erratum: Gastroenterology 1997; 112: 2164).
12. Ramotar K, Henderon E, Szumski R, Louie TJ. Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli. J Clin Microbiol 1995; 33:1114-20.
13. Park CH, Gates KM, Vandel NM, Hixon DL. Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital. Diagn Microbiol Infect Dis 1996; 26:69-72.
14. Kehl K, Havens SP, Behnke CE, Acheson DWK. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 1997; 35:2051-4.
15. Novicki TJ, Daly JA, Mottice SL, Carroll KC. Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J Clin Microbiol 2000; 38:547-51.
16. Klein EJ, Stapp JR, Clausen CR, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002; 141:172-7.
17. Huppertz HI, Busch D, Schmidt H, Aleksic S, Karch H. Diarrhea in young children associated with Escherichia coli non-O157 organisms that produce Shiga-like toxin. J Pediatr 1996; 128:341-6.
18. Banatvala N, Griffin PM, Greene KD, et al. The United States national prospective hemolytic uremic syndrome study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 2001; 183: 1063-70.
19. Banatvala N, Debeukelaer MM, Griffin PM, et al. Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatr Infect Dis J 1996; 15:1008-11.
20. Tarr PI, Fouser LS, Stapleton AE, et al. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2 [see comments]. N Engl J Med 1996; 335:635-8.
21. Olsvik O, Rimstad E, Hornes E, et al. A nested PCR followed by magnetic separation of amplified fragments for detection of Escherichia coli Shiga-like toxin genes. Mol Cell Probes 1991; 5:429-35.
22. Karch H, Bohm H, Schmidt H, Gunzer F, Aleksic S, Heesemann J. Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol 1993; 31: 1200-5.
23. Fratamico J, Franke S, Schmidt A, et al. Detection of Escherichia coli O157:H7 by multiplex PCR. J Clin Microbiol 1995; 33:2188-91.
24. Cebula TA, Payne WL, Feng P. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol 1995; 33:248-50 (erratum: J Clin Microbiol 1995; 33:1048).
25. Barrett TJ, Green JH, Griffin PM, Pavia AT, Ostroff SM, Wachsmuth IK. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol 1991; 23:189-95.
26. Friedman M, Roels TJK, Feldman L, Bibb W, Blake P. Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool. Clin Infect Dis 1999; 29:298-303.
27. Griffin PM. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:739-61.
28. Duncan L, Mai V, Carter A, Carlson JAK, Borczyk A, Karmali MA. Outbreak of gastrointestinal disease - Ontario. Can Dis Wkly Rep 1987; 13:5-8.
29. Salmon RL, Farrell ID, Hutchison JG, et al. A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O157:H7. Epidemiol Infect 1989; 103: 249-54.
30. Rodrigue DC, Mast EE, Greene KD, et al. A university outbreak of Escherichia coli O157:H7 infections associated with roast beef and an unusually benign clinical course. J Infect Dis 1995; 172:1122-5.
31. Centers for Disease Control and Prevention. Surveillance for outbreaks of Escherichia coli O157:H7 infection: summary of 1998 data. Atlanta, GA: Centers for Disease Control and Prevention, Division of Bacterial and Mycotic Diseases, Foodborne and Diarrheal Diseases Branch, 1999:1-3. Available at: http://www.cdc.gov/ncidod/dbmd/disease info/csteec98.pdf. Accessed 15 December 2003.
32. Centers for Disease Control and Prevention. Summary of outbreaks of Escherichia coli O157 and other Shiga toxin-producing E. coli reported to CDC in 1999. Atlanta, GA: Centers for Disease Control and Prevention, Division of Bacterial and Mycotic Diseases, Foodborne and Diarrheal Diseases Branch, 2000:1-3. Available at: http://www.cdc.gov/ ncidod/dbmd/diseaseinfo/files/ ecoli_99summary.pdf. Accessed 15 December 2003.
33. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment in Escherichia coli O157: H7 infections. N Engl J Med 2000; 342:1930-6.
34. Molbak K, Mead PS, Griffin PM. Antimicrobial therapy in patients with Escherichia coli O157:H7 infection. JAMA 2002; 288:1014-6.
35. Brooks JT, Sowers EG, Wells JG, Greene KD, Griffin PM, Strockbine NA. Non-O157 Shiga toxin-producing Escherichia coli reported to CDC, 1983-2000 (abstract 856). In: Program and abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America (San Francisco). Alexandria, VA: Infectious Diseases Society of America, 2001:185
36. Caprioli A, Tozzi AE. Epidemiology of Shiga toxin-producing Escherichia coli infections in continental Europe. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:38-48.
37. Carlson C. Investigation of an Escherichia coli O111:NM outbreak in a daycare in South Dakota [session 22, board 80]. In: Program and abstracts of the International Conference on Emerging Infectious Diseases (Atlanta, GA). Atlanta: Centers for Disease Control and Prevention, 2002:94.
38. Karmali MA, Petric M, Winkler M, et al. Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol 1994; 32:1457-63.
39. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM - South Australia 1995. MMWR Morb Mortal Wkly Rep 1995; 44:550-1.
40. Tanaka H, Ohseto M, Yamashita Y, et al. Bacteriological investigation on an outbreak of acute enteritis associated with verotoxin-producing Escherichia coli O111:H-[in Japanese]. Kansenshogaku Zasshi 1989; 63:1187-94.
41. Caprioli A, Luzzi I, Rosmini F, et al. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis 1994; 169:208-11.
42. Blanco JE, Blanco M, Molinero ME, Peiro E, Mora A, Blanco J. Brote de gastroenteritis asociado con un Escherichia coli vertoxigenico O111:H-VT1+ eae+. Alimentaria 1996; 275:109-13.
43. Scheutz F, Beutin L, Smith HR. Characterization of non-O157 verocytotoxigenic E. coli (VTEC) isolated from patients with haemolytic uremic syndrome (HUS) world-wide from 1982-2000 [abstract 203]. In: Program and abstracts of the 4th International Symposium and Workshop on Shiga Toxin (Verocytotoxin)-Producing Escherichia coli Infections (Kyoto, Japan). VTEC Organizing Committee, 2000:96.
44. Tozzi AE, Caprioli A, Minelli F, et al. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003; 9:106-8.
45. Paton AW, Ratcliff RM, Doyle RM, et al. Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol 1996; 34:1622-7.
46. Boudailliez B, Berquin P, Mariani-Kurkdjian P, et al. Possible person-to-person transmission of Escherichia coli O111-associated hemolytic uremic syndrome. Pediatr Nephrol 1997; 11:36-9.
47. Wells JG, Shipman LD, Greene KD, et al. Isolation of Escherichia coli serotype O157:H7 and other Shiga-like toxin-producing E. coli from dairy cattle. J Clin Microbiol 1991; 29:985-9.
48. Tanaka H, Kondo R, Nishiuchi C, et al. Isolation of verocytotoxin- producing Escherichia coli from cattle and pets [in Japanese]. Kansenshogaku Zasshi 1992; 66:448-55.
49. Bettelheim KA. Role of non-O157 VTEC. J Appl Microbiol 2000; 88: 38S-50S.
50. Wells IG, DeBaukelaer MM, Greene KD, Bopp CA, Barrett TJ, Griffin PM. Use of immunomagnetic separation to implicate cattle as a source of Shiga toxin-producing Escherichia coli O111ac:nonmotile infection. In: Program and abstracts of the 100th General Meeting of the American Society for Microbiology (Los Angeles). Washington, DC: American Society for Microbiology, 2000. Available at: http://www .asmusa.org/memonly/abstracts/AbstractView.asp? AbstractID=29996. Accessed 15 December 2003.
51. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 1990; 162:553-6.
52. Inclusion of enterohemorrhagic Escherichia coli (EHEC) in the national public health surveillance system (NPHSS) (and subsume E. coli O157: H7 under EHEC). Atlanta, GA: Council of State and Territorial Epidemiologists, 2000. Available at: http://www.cste.org/ps/2000/2000 -id-01.htm. Accessed 15 December 2003.